The Silent Epidemic of Exclusive University Licensing Policies on Compounds for Neglected Diseases and Beyond

Abstract

1 School of Medicine, University of California, San Francisco, California, United States of America, 2 Universities Allied for Essential Medicines (UAEM), Berkeley, California, United States of America, 3 Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, California, United States of America, 4 Berkeley Law School, University of California, Berkeley, California, United States of America, 5 Tri-Institutional MD–PhD Program, Weill Cornell/Rockefeller/Sloan-Kettering Institute, New York, New York, United States of America

DOI: 10.1371/journal.pntd.0000570

Extracted Key Phrases

Cite this paper

@inproceedings{Chen2010TheSE, title={The Silent Epidemic of Exclusive University Licensing Policies on Compounds for Neglected Diseases and Beyond}, author={Connie Chen and C. Taylor Gilliland and Jay Purcell and S. P. Kishore}, booktitle={PLoS neglected tropical diseases}, year={2010} }